Achyut Healthcare
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Achyut Healthcare's board approved a scheme of amalgamation to merge the company with and into Zenith Healthcare Limited, a group entity engaged in pharmaceutical manufacturing. Under the terms, Achyut shareholders will receive 119 equity shares of Zenith Healthcare for every 50 shares held. The transferor company, Achyut, had total assets of ₹38.09 crore and revenue of ₹11.97 crore in FY26, while Zenith had assets of ₹10.99 crore and revenue of ₹10.94 crore. The merger aims to streamline group structure, combine manufacturing capabilities, and unlock synergies across their API trading and formulation businesses. The scheme remains subject to NCLT and shareholder approvals, and a no-objection letter from BSE.
Powered by Tijori
Achyut Healthcare's board approved a scheme of amalgamation to merge the company with and into Zenith Healthcare Limited, a group entity engaged in pharmaceutical manufacturing. Under the terms, Achyut shareholders will receive 119 equity shares of Zenith Healthcare for every 50 shares held. The transferor company, Achyut, had total assets of ₹38.09 crore and revenue of ₹11.97 crore in FY26, while Zenith had assets of ₹10.99 crore and revenue of ₹10.94 crore. The merger aims to streamline group structure, combine manufacturing capabilities, and unlock synergies across their API trading and formulation businesses. The scheme remains subject to NCLT and shareholder approvals, and a no-objection letter from BSE.
Powered by Tijori
Oct 10 (Reuters) - Achyut Healthcare Ltd ACHU.BO:
ACHYUT HEALTHCARE LTD - TO CONSIDER SUB-DIVISION OF SHARES
ACHYUT HEALTHCARE LTD - TO CONSIDER AND RECOMMEND ISSUE OF BONUS SHARES
Source text for Eikon: ID:nBSE9PnkNt
Further company coverage: ACHU.BO
(([email protected];))
Oct 10 (Reuters) - Achyut Healthcare Ltd ACHU.BO:
ACHYUT HEALTHCARE LTD - TO CONSIDER SUB-DIVISION OF SHARES
ACHYUT HEALTHCARE LTD - TO CONSIDER AND RECOMMEND ISSUE OF BONUS SHARES
Source text for Eikon: ID:nBSE9PnkNt
Further company coverage: ACHU.BO
(([email protected];))
Nov 15 (Reuters) - Achyut Healthcare Ltd ACHU.BO:
TO ISSUE UPTO 3.7 MILLION SHARES AT ISSUE PRICE OF 56 RUPEES EACH
Source text for Eikon: ID:nBSE66WWsZ
Further company coverage: ACHU.BO
(([email protected];;))
Nov 15 (Reuters) - Achyut Healthcare Ltd ACHU.BO:
TO ISSUE UPTO 3.7 MILLION SHARES AT ISSUE PRICE OF 56 RUPEES EACH
Source text for Eikon: ID:nBSE66WWsZ
Further company coverage: ACHU.BO
(([email protected];;))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Achyut Healthcare do?
Achyut Healthcare Limited trades a wide range of healthcare and pharmaceutical products including Cenzure, Arpimune, and Infrared thermometers among others.
Who are the competitors of Achyut Healthcare?
Achyut Healthcare major competitors are Vaidya Sane Ayur Lab, Brooks Laboratories, Coral Laboratories, Panchsheel Organics, Kimia Biosciences, Alpa Laboratories, Gennex Laboratories. Market Cap of Achyut Healthcare is ₹190 Crs. While the median market cap of its peers are ₹208 Crs.
Is Achyut Healthcare financially stable compared to its competitors?
Achyut Healthcare seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Achyut Healthcare pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Achyut Healthcare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Achyut Healthcare allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Achyut Healthcare balance sheet?
Balance sheet of Achyut Healthcare is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Achyut Healthcare improving?
Yes, profit is increasing. The profit of Achyut Healthcare is ₹0.55 Crs for Mar 2025, ₹0.5 Crs for Mar 2024 and ₹0.23 Crs for Mar 2023
Is the debt of Achyut Healthcare increasing or decreasing?
The net debt of Achyut Healthcare is decreasing. Latest net debt of Achyut Healthcare is -₹3.29 Crs as of Mar-26. This is less than Mar-25 when it was -₹1.99 Crs.
Is Achyut Healthcare stock expensive?
There is insufficient historical data to gauge this. Latest PE of Achyut Healthcare is 570.27
Has the share price of Achyut Healthcare grown faster than its competition?
Achyut Healthcare has given better returns compared to its competitors. Achyut Healthcare has grown at ~62.19% over the last 4yrs while peers have grown at a median rate of 3.31%
Is the promoter bullish about Achyut Healthcare?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Achyut Healthcare is 47.4% and last quarter promoter holding is 47.71%
Are mutual funds buying/selling Achyut Healthcare?
There is Insufficient data to gauge this.